Bruderman Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-8,658
Closed -$304K 113
2019
Q3
$304K Sell
8,658
-346,798
-98% -$12.6M 0.08% 101
2019
Q2
$14.6M Sell
355,456
-6,810
-2% -$270K 3.45% 5
2019
Q1
$14.6M Sell
362,266
-22,217
-6% -$890K 3.2% 5
2018
Q4
$15.9M Sell
384,483
-1,990
-0.5% -$82.6K 4.1% 3
2018
Q3
$16.2M Buy
386,473
+25,815
+7% +$994K 3.71% 3
2018
Q2
$12.4M Sell
360,658
-2,339
-0.6% -$79.9K 3.02% 7
2018
Q1
$12.2M Sell
362,997
-830
-0.2% -$28.5K 2.93% 9
2017
Q4
$12.5M Buy
363,827
+1,089
+0.3% +$37.1K 3.18% 9
2017
Q3
$12.3M Sell
362,738
-782
-0.2% -$25.1K 3.18% 10
2017
Q2
$11.6M Buy
363,520
+35,269
+11% +$1.11M 3.09% 11
2017
Q1
$10.7M Buy
328,251
+20,207
+7% +$637K 3.08% 9
2016
Q4
$9.49M Buy
308,044
+10,158
+3% +$310K 2.86% 9
2016
Q3
$9.57M Buy
297,886
+32,248
+12% +$1.08M 2.86% 9
2016
Q2
$8.87M Sell
265,638
-1,212
-0.5% -$38.7K 2.78% 9
2016
Q1
$7.5M Buy
266,850
+93,219
+54% +$2.66M 2.61% 11
2015
Q4
$5.32M Buy
173,631
+5,774
+3% +$182K 2% 14
2015
Q3
$5M Buy
167,857
+38,189
+29% +$1.22M 1.97% 17
2015
Q2
$4.13M Buy
129,668
+43,840
+51% +$1.43M 1.58% 18
2015
Q1
$2.83M Buy
+85,828
New +$2.73M 1.11% 23

Other funds holding PFE

Bruderman Asset Management's PFE Position: Q4 2019 in Review

Bruderman Asset Management sold out of Pfizer (PFE) in Q4 2019, closing a stake of 8,658 shares — an estimated $304K sold.

Bruderman Asset Management first reported a position in PFE in Q1 2015 and held it in 19 quarters. The position peaked at $16.2M in Q3 2018. 2,524 funds tracked by Wall St. Rank hold PFE as of Q4 2019.

  • Bruderman Asset Management reported no remaining Pfizer position as of Q4 2019 after selling out during the quarter.
  • Bruderman Asset Management sold 8,658 Pfizer shares in Q4 2019, an estimated $304K.
  • Bruderman Asset Management first reported a position in Pfizer in Q1 2015 and held it in 19 quarters.
  • Bruderman Asset Management's Pfizer position peaked at $16.2M in Q3 2018.
  • 2,524 funds tracked by Wall St. Rank held Pfizer as of Q4 2019.

Based on Bruderman Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.